UGI Reports Strong Fiscal 2024 Results
| BIVRX Fund | USD 17.25 0.03 0.17% |
Slightly above 62% of Balter Invenomic's investor base is looking to short. The analysis of overall sentiment of trading Balter Invenomic Fund mutual fund suggests that many investors are alarmed at this time. Balter Invenomic's investing sentiment can be driven by a variety of factors including economic data, Balter Invenomic's earnings reports, geopolitical events, and overall market trends.
Balter |
UGI Corporation today reported financial results for the fiscal year ended September 30, 2024 and provided guidance for fiscal year 2025. HEADLIN
Read at gurufocus.com
 |
Balter Invenomic Fundamental Analysis
We analyze Balter Invenomic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Balter Invenomic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Balter Invenomic based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Five Year Return
Five Year Return Comparative Analysis
Balter Invenomic is currently under evaluation in five year return among similar funds. Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
Balter Invenomic Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Balter Invenomic mutual fund to make a market-neutral strategy. Peer analysis of Balter Invenomic could also be used in its relative valuation, which is a method of valuing Balter Invenomic by comparing valuation metrics with similar companies.
Peers
Balter Invenomic Related Equities
| LMISX | Qs Us | 0.53 |
| ||
| ALCKX | Ab Large | 0.75 |
| ||
| NEAMX | Neiman Large | 0.86 |
| ||
| OLGCX | Jpmorgan Large | 0.89 |
| ||
| LGPSX | Profunds-large Cap | 1.02 |
|
Other Information on Investing in Balter Mutual Fund
Balter Invenomic financial ratios help investors to determine whether Balter Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Balter with respect to the benefits of owning Balter Invenomic security.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |